Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The capsular polysaccharide of Streptococcus pneumoniae serotype 18C is a complex carbohydrate structure that forms the outermost layer of the bacterium. It serves as a critical virulence factor by protecting the pathogen from host phagocytosis and complement-mediated killing, thereby facilitating invasive disease. The chemical structure of the 18C polysaccharide typically consists of a branched pentasaccharide repeating unit containing D-glucose, D-galactose, L-rhamnose, and N-acetyl-D-glucosamine, often substituted with glycerol phosphate. Due to its high immunogenicity when conjugated to carrier proteins, it is a primary component in several multivalent pneumococcal conjugate vaccines (PCVs) and polysaccharide vaccines. These vaccines aim to elicit protective IgG antibodies that recognize the 18C capsule, leading to the opsonization and clearance of the bacteria by the host immune system.
Induction of active immunity through the production of serotype-specific opsonizing antibodies that facilitate phagocytosis and killing of Streptococcus pneumoniae.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capsular polysaccharide of Streptococcus pneumoniae serotype 18C (CPS18C).